S

Savara
D

SVRA

3.36500
USD
-0.06
(-1.75%)
مغلق
حجم التداول
28,459
الربح لكل سهم
-0
العائد الربحي
-
P/E
-7
حجم السوق
581,596,243
أصول ذات صلة الأخبار المقالات

العنوان: Savara

القطاع: Healthcare
الصناعة: Biotechnology
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.